Investor Relations |
|
Our primary goal is to provide products that help improve the lives of patients with rare CNS and inflammatory diseases and disorders, and by doing this successfully we will build long term value for our shareholders.
Recent Releases
Jul 29, 2010
Questcor to Participate in Upcoming Conferences
Jul 28, 2010
Questcor Reports Second Quarter 2010 Results
Jul 15, 2010
Questcor Announces Second Quarter 2010 Earnings Release Date and Conference Call
Events & Presentations
Aug 5, 2010 at 4:00 PM ET
Questcor Pharmaceuticals, Inc. at the BMO Capital Markets 10th Annual Focus on Healthcare Conference
Jul 28, 2010 at 4:30 PM ET
Q2 2010 Questcor Pharmaceuticals, Inc. Earnings Conference Call
| Stock Chart | |
|---|---|
|
|
|
| Stock Quote | |
| Questcor Pharmaceuticals, Inc. | |
| Price: | 9.91 |
| Change: | - 0.03 |
| Day High: | 10.11 |
| Day Low: | 9.75 |
| Volume: | 343,000 |
| Delayed at least 20 minutes. Provided by eSignal. |
|
| Investor Presentation |
|---|
 |
Transfer Agent
Computershare Trust Co., Inc.Phone 303-262-0600
Corporate Counsel
Stradling Yocca Carlson & RauthNewport Beach, CA
Independent Accountants
Odenberg Ullakko Muranishi & Co. LLPSan Francisco, CA
Investor Relations Contacts
Phone 510-400-0700or
Doug Sherk, EVC Group, 415-896-6820